Use of caffeinated substances and risk of crashes in long distance drivers of commercial vehicles: case-control study

Objective To determine whether there is an association between use of substances that contain caffeine and the risk of crash in long distance commercial vehicle drivers.Design Case-control study.Setting New South Wales (NSW) and Western Australia (WA), Australia.Participants 530 long distance driver...

Full description

Saved in:
Bibliographic Details
Published inBMJ (Online) Vol. 346; no. 7900; p. 13
Main Authors Sharwood, Lisa N, Elkington, Jane, Meuleners, Lynn, Ivers, Rebecca, Boufous, Soufiane, Stevenson, Mark
Format Journal Article
LanguageEnglish
Published England British Medical Journal Publishing Group 19.03.2013
BMJ Publishing Group
BMJ Publishing Group LTD
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Objective To determine whether there is an association between use of substances that contain caffeine and the risk of crash in long distance commercial vehicle drivers.Design Case-control study.Setting New South Wales (NSW) and Western Australia (WA), Australia.Participants 530 long distance drivers of commercial vehicles who were recently involved in a crash attended by police (cases) and 517 control drivers who had not had a crash while driving a commercial vehicle in the past 12 months.Main outcome measure The likelihood of a crash associated with the use of substances containing caffeine after adjustment for factors including age, health disorders, sleep patterns, and symptoms of sleep disorders as well as exposures such as kilometres driven, hours slept, breaks taken, and night driving schedules.Results Forty three percent of drivers reported consuming substances containing caffeine, such as tea, coffee, caffeine tablets, or energy drinks for the express purpose of staying awake. Only 3% reported using illegal stimulants such as amphetamine (“speed”); 3,4 methylenedioxymethamphetamine (ecstasy); and cocaine. After adjustment for potential confounders, drivers who consumed caffeinated substances for this purpose had a 63% reduced likelihood of crashing (odds ratio 0.37, 95% confidence interval 0.27 to 0.50) compared with drivers who did not take caffeinated substances.Conclusions Caffeinated substances are associated with a reduced risk of crashing for long distance commercial motor vehicle drivers. While comprehensive mandated strategies for fatigue management remain a priority, the use of caffeinated substances could be a useful adjunct strategy in the maintenance of alertness while driving.
AbstractList STUDY QUESTION Is there an association between the use of substances containing caffeine and the risk of crash in long distance drivers of commercial motor vehicles? SUMMARY ANSWER Consuming caffeinated substances for the purpose of staying awake while driving can significantly reduce the risk of a crash. WHAT IS KNOWN AND WHAT THIS PAPER ADDS Long distance drivers of commercial vehicles are at considerable risk of daytime fatigue and are known to use stimulants and substances containing caffeine to stay awake. The effectiveness of caffeine for enhancing alertness during monotonous task performance has previously been demonstrated in laboratory and driving simulator settings. After adjustment for possible confounding factors, consumption of caffeinated substances to assist driving alertness was associated with a reduced risk of crashing among long distance commercial motor vehicle drivers.
Objective To determine whether there is an association between use of substances that contain caffeine and the risk of crash in long distance commercial vehicle drivers. Design Case-control study. Setting New South Wales (NSW) and Western Australia (WA), Australia. Participants 530 long distance drivers of commercial vehicles who were recently involved in a crash attended by police (cases) and 517 control drivers who had not had a crash while driving a commercial vehicle in the past 12 months. Main outcome measure The likelihood of a crash associated with the use of substances containing caffeine after adjustment for factors including age, health disorders, sleep patterns, and symptoms of sleep disorders as well as exposures such as kilometres driven, hours slept, breaks taken, and night driving schedules. Results Forty three percent of drivers reported consuming substances containing caffeine, such as tea, coffee, caffeine tablets, or energy drinks for the express purpose of staying awake. Only 3% reported using illegal stimulants such as amphetamine (“speed”); 3,4 methylenedioxymethamphetamine (ecstasy); and cocaine. After adjustment for potential confounders, drivers who consumed caffeinated substances for this purpose had a 63% reduced likelihood of crashing (odds ratio 0.37, 95% confidence interval 0.27 to 0.50) compared with drivers who did not take caffeinated substances. Conclusions Caffeinated substances are associated with a reduced risk of crashing for long distance commercial motor vehicle drivers. While comprehensive mandated strategies for fatigue management remain a priority, the use of caffeinated substances could be a useful adjunct strategy in the maintenance of alertness while driving.
To determine whether there is an association between use of substances that contain caffeine and the risk of crash in long distance commercial vehicle drivers. Case-control study. New South Wales (NSW) and Western Australia (WA), Australia. 530 long distance drivers of commercial vehicles who were recently involved in a crash attended by police (cases) and 517 control drivers who had not had a crash while driving a commercial vehicle in the past 12 months. The likelihood of a crash associated with the use of substances containing caffeine after adjustment for factors including age, health disorders, sleep patterns, and symptoms of sleep disorders as well as exposures such as kilometres driven, hours slept, breaks taken, and night driving schedules. Forty three percent of drivers reported consuming substances containing caffeine, such as tea, coffee, caffeine tablets, or energy drinks for the express purpose of staying awake. Only 3% reported using illegal stimulants such as amphetamine ("speed"); 3,4 methylenedioxymethamphetamine (ecstasy); and cocaine. After adjustment for potential confounders, drivers who consumed caffeinated substances for this purpose had a 63% reduced likelihood of crashing (odds ratio 0.37, 95% confidence interval 0.27 to 0.50) compared with drivers who did not take caffeinated substances. Caffeinated substances are associated with a reduced risk of crashing for long distance commercial motor vehicle drivers. While comprehensive mandated strategies for fatigue management remain a priority, the use of caffeinated substances could be a useful adjunct strategy in the maintenance of alertness while driving.
OBJECTIVETo determine whether there is an association between use of substances that contain caffeine and the risk of crash in long distance commercial vehicle drivers.DESIGNCase-control study.SETTINGNew South Wales (NSW) and Western Australia (WA), Australia.PARTICIPANTS530 long distance drivers of commercial vehicles who were recently involved in a crash attended by police (cases) and 517 control drivers who had not had a crash while driving a commercial vehicle in the past 12 months.MAIN OUTCOME MEASUREThe likelihood of a crash associated with the use of substances containing caffeine after adjustment for factors including age, health disorders, sleep patterns, and symptoms of sleep disorders as well as exposures such as kilometres driven, hours slept, breaks taken, and night driving schedules.RESULTSForty three percent of drivers reported consuming substances containing caffeine, such as tea, coffee, caffeine tablets, or energy drinks for the express purpose of staying awake. Only 3% reported using illegal stimulants such as amphetamine ("speed"); 3,4 methylenedioxymethamphetamine (ecstasy); and cocaine. After adjustment for potential confounders, drivers who consumed caffeinated substances for this purpose had a 63% reduced likelihood of crashing (odds ratio 0.37, 95% confidence interval 0.27 to 0.50) compared with drivers who did not take caffeinated substances.CONCLUSIONSCaffeinated substances are associated with a reduced risk of crashing for long distance commercial motor vehicle drivers. While comprehensive mandated strategies for fatigue management remain a priority, the use of caffeinated substances could be a useful adjunct strategy in the maintenance of alertness while driving.
Author Sharwood, Lisa N
Stevenson, Mark
Ivers, Rebecca
Boufous, Soufiane
Elkington, Jane
Meuleners, Lynn
Author_xml – sequence: 1
  givenname: Lisa N
  surname: Sharwood
  fullname: Sharwood, Lisa N
  email: lsharwood@george.org.au
  organization: Monash University Accident Research Centre, Monash Injury Research Institute, VIC 3800, Australia
– sequence: 2
  givenname: Jane
  surname: Elkington
  fullname: Elkington, Jane
  email: lsharwood@george.org.au
  organization: Monash University Accident Research Centre, Monash Injury Research Institute, VIC 3800, Australia
– sequence: 3
  givenname: Lynn
  surname: Meuleners
  fullname: Meuleners, Lynn
  email: lsharwood@george.org.au
  organization: Monash University Accident Research Centre, Monash Injury Research Institute, VIC 3800, Australia
– sequence: 4
  givenname: Rebecca
  surname: Ivers
  fullname: Ivers, Rebecca
  email: lsharwood@george.org.au
  organization: Monash University Accident Research Centre, Monash Injury Research Institute, VIC 3800, Australia
– sequence: 5
  givenname: Soufiane
  surname: Boufous
  fullname: Boufous, Soufiane
  email: lsharwood@george.org.au
  organization: Monash University Accident Research Centre, Monash Injury Research Institute, VIC 3800, Australia
– sequence: 6
  givenname: Mark
  surname: Stevenson
  fullname: Stevenson, Mark
  email: lsharwood@george.org.au
  organization: Monash University Accident Research Centre, Monash Injury Research Institute, VIC 3800, Australia
BackLink https://www.ncbi.nlm.nih.gov/pubmed/23511947$$D View this record in MEDLINE/PubMed
BookMark eNp10UFrFDEUB_AgFbuuPfgBlIAe7GFqMslkJr3JVmtxVSit15BJXuxsZ5KazBT77c3utEUET4G8H38e7_8c7fngAaGXlBxRysT7dtgcOUo5eYIWtK5EQRvG9tCCyEoWDWXNPjpIaUMIKVndSFE9Q_slqyiVvF6g6TIBDg4b7Rx0Xo9gcZraNGpvIGHtLY5dut6RqNNV_us87oP_iW03K2xjdwsx7UwYBoim0z2-havO9JCOc3aCwgQ_xtDjNE727gV66nSf4OD-XaLLTx8vVp-L9ffTs9WHddFyUY2FcEBcWWpGeGVqWZe0krJtGgAHjBhpdQuCC6sbVxJHDdeWW6e1Y4yzxpZsid7NuTcx_JogjWrokoG-1x7ClBRltBGScCIyffMP3YQp-rydypeqBKlqyrI6nJWJIaUITt3EbtDxTlGitnWoXIfa1ZHt6_vEqR3APsqH42fwagabNIb415xLznNzS1TM83xo-P041_FaiZrVlfr2Y6VOzk--ri_Ov6itfzv77Q7_3-sPRZ2syQ
CitedBy_id crossref_primary_10_1080_10826084_2020_1750032
crossref_primary_10_3390_s140917491
crossref_primary_10_1093_sleep_zsad324
crossref_primary_10_1007_s15006_013_1003_0
crossref_primary_10_1177_1557234X15574827
crossref_primary_10_1016_j_ssci_2020_104664
crossref_primary_10_1080_19439962_2018_1458765
crossref_primary_10_1097_JOM_0000000000000132
crossref_primary_10_1111_nure_12137
crossref_primary_10_1155_2015_105256
crossref_primary_10_1177_1088868315609487
crossref_primary_10_1016_j_jsmc_2020_02_017
crossref_primary_10_1111_add_16390
crossref_primary_10_1016_j_mayocp_2014_01_018
crossref_primary_10_1097_JOM_0000000000000534
crossref_primary_10_1002_hup_2529
crossref_primary_10_1186_s12889_020_09421_x
crossref_primary_10_1016_j_ssci_2020_104718
crossref_primary_10_1016_j_neubiorev_2016_09_001
crossref_primary_10_1177_1557234X15573949
crossref_primary_10_18332_tpc_142321
crossref_primary_10_3390_ijerph15102121
crossref_primary_10_1016_j_tra_2015_09_016
crossref_primary_10_1016_j_jsmc_2019_08_005
crossref_primary_10_1213_ANE_0000000000004252
crossref_primary_10_1016_j_heliyon_2021_e06512
crossref_primary_10_1007_s41782_017_0019_4
crossref_primary_10_1371_journal_pone_0207154
crossref_primary_10_3389_frym_2017_00027
crossref_primary_10_1016_j_aap_2017_11_022
crossref_primary_10_1016_j_jsmc_2016_10_012
crossref_primary_10_1016_j_jsmc_2022_03_001
ContentType Journal Article
Copyright Sharwood et al 2013
BMJ Publishing Group Ltd 2012
Copyright: 2013 © Sharwood et al 2013
Copyright_xml – notice: Sharwood et al 2013
– notice: BMJ Publishing Group Ltd 2012
– notice: Copyright: 2013 © Sharwood et al 2013
DBID 9YT
ACMMV
BSCLL
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
3V.
7RV
7X7
7XB
88I
8AF
8FE
8FH
8FI
8FJ
8FK
8G5
ABUWG
AFKRA
ASE
AZQEC
BBNVY
BENPR
BHPHI
BTHHO
CCPQU
DWQXO
FPQ
FYUFA
GHDGH
GNUQQ
GUQSH
HCIFZ
K6X
K9.
KB0
LK8
M2O
M2P
M7P
MBDVC
NAPCQ
PQEST
PQQKQ
PQUKI
PRINS
Q9U
7X8
DOI 10.1136/bmj.f1140
DatabaseName BMJ Journals (Open Access)
BMJ Journals:Open Access
Istex
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
ProQuest Central (Corporate)
ProQuest Nursing & Allied Health Database
ProQuest Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Science Database (Alumni Edition)
STEM Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Research Library (Alumni Edition)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
British Nursing Index
ProQuest Central Essentials
Biological Science Collection
AUTh Library subscriptions: ProQuest Central
ProQuest Natural Science Collection
BMJ Journals
ProQuest One Community College
ProQuest Central
British Nursing Index (BNI) (1985 to Present)
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
Research Library Prep
SciTech Premium Collection (Proquest) (PQ_SDU_P3)
British Nursing Index
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
Biological Sciences
ProQuest Research Library
ProQuest Science Journals
Biological Science Database
Research Library (Corporate)
Nursing & Allied Health Premium
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Research Library Prep
ProQuest Central Student
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest AP Science
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
Research Library (Alumni Edition)
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Central
Health Research Premium Collection
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
ProQuest Research Library
ProQuest Science Journals (Alumni Edition)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest Science Journals
ProQuest One Academic Eastern Edition
British Nursing Index
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
BMJ Journals
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList

MEDLINE
Research Library Prep

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: ACMMV
  name: BMJ Journals:Open Access
  url: https://journals.bmj.com/
  sourceTypes: Publisher
– sequence: 4
  dbid: BENPR
  name: AUTh Library subscriptions: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1756-1833
EndPage 13
ExternalDocumentID 10_1136_bmj_f1140
23511947
23494481
ark_67375_NVC_DRDMLTRK_1
ttp://bmj.com/content/346/bmj.f1140.full
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations Western Australia
New South Wales
GeographicLocations_xml – name: Western Australia
– name: New South Wales
GroupedDBID 0R~
23N
39C
4.4
40O
53G
5GY
7RV
7X7
88I
8AF
8F7
8FE
8FH
8FI
8FJ
8G5
9YT
AACGO
AANCE
AAWJN
ABBHK
ABIVO
ABJNI
ABPLY
ABTLG
ABUWG
ABVAJ
ABXSQ
ACGFS
ACGOD
ACMFJ
ACMMV
ACPRK
ADACV
ADCEG
ADULT
AEUPB
AEXZC
AFKRA
AGFXO
AHMBA
AHNKE
AHQMW
AJYBZ
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AQVQM
ASPBG
AZFZN
AZQEC
BBNVY
BENPR
BHPHI
BPHCQ
BTHHO
C45
CCPQU
CS3
DCCCD
DOOOF
DWQXO
EBS
EJD
F5P
FEDTE
FYUFA
GNUQQ
GUQSH
H13
HAJ
HCIFZ
HMCUK
HVGLF
HZ~
IPSME
JAAYA
JBMMH
JENOY
JHFFW
JKQEH
JLS
JLXEF
JPM
JSG
JSODD
JST
L7B
LK8
M2O
M2P
M7P
NAPCQ
NXWIF
O9-
OVD
PQQKQ
PROAC
R53
RHF
RHI
RMJ
RV8
SA0
TEORI
UKHRP
VVN
WOQ
YFH
YQY
.GJ
2WC
3O-
AAKAS
ADBBV
ADZCM
ADZLD
AEQTP
BAWUL
BSCLL
CAG
COF
DIK
DNJUQ
DWIUU
EX3
HQ3
HTVGU
NTWIH
UHU
WHG
WOW
AHPSJ
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
3V.
7XB
8FK
ASE
FPQ
K6X
K9.
MBDVC
PQEST
PQUKI
PRINS
Q9U
7X8
ADQXQ
ID FETCH-LOGICAL-b465t-6fe0f22a3045c79721599b88eefe30c9dabe646da8f20f1c4ad4dfaaf33438d23
IEDL.DBID 9YT
ISSN 0959-8138
1756-1833
IngestDate Fri Aug 16 06:10:38 EDT 2024
Thu Oct 10 16:29:43 EDT 2024
Fri Aug 23 02:19:21 EDT 2024
Sat Sep 28 07:51:52 EDT 2024
Fri Feb 02 07:03:33 EST 2024
Wed Jan 17 04:59:24 EST 2024
Wed Aug 21 02:54:58 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 7900
Language English
License This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/2.0/ and http://creativecommons.org/licenses/by-nc/2.0/legalcode.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-b465t-6fe0f22a3045c79721599b88eefe30c9dabe646da8f20f1c4ad4dfaaf33438d23
Notes href:bmj-346-bmj-f1140.pdf
local:bmj;346/mar18_3/f1140
istex:2F2E364E1C512CAD0EB4EA18F54A70208941A2A7
ark:/67375/NVC-DRDMLTRK-1
ArticleID:shal006564
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink http://dx.doi.org/10.1136/bmj.f1140
PMID 23511947
PQID 1945605713
PQPubID 2043523
PageCount 1
ParticipantIDs proquest_miscellaneous_1318690406
proquest_journals_1945605713
crossref_primary_10_1136_bmj_f1140
pubmed_primary_23511947
jstor_primary_23494481
istex_primary_ark_67375_NVC_DRDMLTRK_1
bmj_primary_10_1136_bmj_f1140
PublicationCentury 2000
PublicationDate 2013-03-19
PublicationDateYYYYMMDD 2013-03-19
PublicationDate_xml – month: 03
  year: 2013
  text: 2013-03-19
  day: 19
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle BMJ (Online)
PublicationTitleAlternate BMJ
PublicationYear 2013
Publisher British Medical Journal Publishing Group
BMJ Publishing Group
BMJ Publishing Group LTD
Publisher_xml – name: British Medical Journal Publishing Group
– name: BMJ Publishing Group
– name: BMJ Publishing Group LTD
References 2011; 214
2010; 10
2009; 10
2012; 222
1991; 14
2004; 170
2000; 32
2007; 166
2011; 22
2006; 29
2001; 16
1999; 51
2011; 14
1995; 18
2001; 33
2010; 5
2006; 144
2005; 45
2009; 203
2001; 20
1991; 6
1996; 33
2001; 10
References_xml – volume: 166
  start-page: 1320
  year: 2007
  publication-title: Am J Epidemiol
– volume: 22
  start-page: 24
  year: 2011
  publication-title: Australian College Road Safety J
– volume: 33
  start-page: 306
  year: 1996
  publication-title: Psychophysiology
– volume: 33
  start-page: 31
  year: 2001
  publication-title: Accid Anal Prev
– volume: 20
  start-page: 83
  year: 2001
  publication-title: Amino Acids
– volume: 222
  start-page: 337
  year: 2012
  publication-title: Psychopharmacol
– volume: 14
  start-page: 540
  year: 1991
  publication-title: Sleep
– volume: 170
  start-page: 1014
  year: 2004
  publication-title: Am J Resp Crit Care Med
– volume: 6
  start-page: 119
  year: 1991
  publication-title: Human Psychopharmacol
– volume: 32
  start-page: 493
  year: 2000
  publication-title: Accid Anal Prev
– volume: 51
  start-page: 83
  year: 1999
  publication-title: Pharmacol Rev
– volume: 18
  start-page: 158
  year: 1995
  publication-title: Sleep
– volume: 16
  start-page: 523
  year: 2001
  publication-title: Human Psychopharmacol
– volume: 10
  start-page: 1016
  year: 2009
  publication-title: Sleep Med
– volume: 144
  start-page: 785
  year: 2006
  publication-title: Ann Intern Med
– volume: 14
  start-page: 89
  year: 2011
  publication-title: Nutr Neurosci
– volume: 10
  start-page: 162
  year: 2010
  publication-title: BMC Public Health
– volume: 214
  start-page: 737
  year: 2011
  publication-title: Psychopharmacol
– volume: 29
  start-page: 39
  year: 2006
  publication-title: Sleep
– volume: 45
  start-page: 535
  year: 2005
  publication-title: Crit Rev Food Sci Nutr
– volume: 203
  start-page: 571
  year: 2009
  publication-title: Psychopharmacol
– volume: 5
  start-page: CD008508
  year: 2010
  publication-title: Cochrane Database Syst Rev
– volume: 10
  start-page: 203
  year: 2001
  publication-title: J Sleep Res
SSID ssj0002378965
Score 2.1149592
Snippet Objective To determine whether there is an association between use of substances that contain caffeine and the risk of crash in long distance commercial...
STUDY QUESTION Is there an association between the use of substances containing caffeine and the risk of crash in long distance drivers of commercial motor...
To determine whether there is an association between use of substances that contain caffeine and the risk of crash in long distance commercial vehicle drivers....
OBJECTIVETo determine whether there is an association between use of substances that contain caffeine and the risk of crash in long distance commercial vehicle...
SourceID proquest
crossref
pubmed
jstor
istex
bmj
SourceType Aggregation Database
Index Database
Publisher
StartPage 13
SubjectTerms Accidents, Traffic - prevention & control
Accidents, Traffic - statistics & numerical data
Adult
Age Factors
Alcohol
Alertness
Amphetamines
Attention - drug effects
Attention - physiology
Automobile Driving - statistics & numerical data
Beverages
Caffeine
Caffeine - administration & dosage
Case control studies
Cocaine
Coffee
Commercial vehicles
Confidence Intervals
Drug use
Energy drinks
Fatigue
Female
Humans
Incidence
Injury prevention
Laboratories
Long distance telephone services
Male
MDMA
Middle Aged
Motor vehicles
New South Wales - epidemiology
Odds Ratio
Reference Values
Risk Assessment
Sex Factors
Sleep
Sleep disorders
Stimulants
Tablets
Tea
Time Factors
Vehicles
Western Australia - epidemiology
SummonAdditionalLinks – databaseName: AUTh Library subscriptions: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LbxMxELagkRAXxKuw0CKDEDfTXdvr3eWCoA9VQCIUNai3lZ80PHZLNkH8fGYcJ8CB3ix7NIf5_JiXZwh5bmyjK547VtVCMIw0MV1YwzjXMjfKgU2Cv5HHE3U6k-_Oy_PkcBtSWuXmTowXtest-sgPwNiGx7kEm-r15Q-GXaMwuppaaFwnI15IDNOO3h5PPk63XhYuqrpRZSopVAh1YL5_eRnACMAfbTD-5zkaoWR_bTIT_69zxrfn5Da5lZRG-maN8h1yzXd3yY1xCovfI6vZ4GkfqNUh-HkH6qOjA9wIS4R0oLpzFFPII8lCDxcwN-_ot777TN18TUXdImZoRJoevdnoS6c__UXMm3sFvAfPUmI7jUVp75PZyfHZ4SlL_RSYkapcMhV8HgAEDI7aCsv2lE1j6tr74EVuG6eNV1I5XQeeh8JK7aQLWgchAETHxS7Z6frOPyS0ATtLKAcs6lxWzjShtkXuCg3gCmNDRvZBuO3lumJGGy0NoVqci8LPyLON2K8iehEB2VLoxVfMQ6vKdvLpsD2aHo0_nE3ft0VGdiNiW0KORXdkDQt7GwjbdDaH9s9OysjT7TKcKgyV6M73K6ARsVUXaDsZebCG_i_mGHuV1aOrmT8mN3lsnSFY0eyRneVi5fdBgVmaJ2mX_gbYH_AD
  priority: 102
  providerName: ProQuest
Title Use of caffeinated substances and risk of crashes in long distance drivers of commercial vehicles: case-control study
URI http://dx.doi.org/10.1136/bmj.f1140
https://api.istex.fr/ark:/67375/NVC-DRDMLTRK-1/fulltext.pdf
https://www.jstor.org/stable/23494481
https://www.ncbi.nlm.nih.gov/pubmed/23511947
https://www.proquest.com/docview/1945605713
https://search.proquest.com/docview/1318690406
Volume 346
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1bb9MwFD4aq4R4QdzGAltlLuItkMSOHfM2uk0TkApV7VSeIju2WbkkqGkRP59jN62YxOUpkX1iKeeL5e9ccg7Ac11LJbLExKKgNPaRpliltY6zTLFEc4M2if8buRzzixl7O8_ne_DszxH8lPJX-tvnlw5ZO9rlgwzZre_PID9Od46UjIpC8ryvGnTtCTwv8P7aiTPwyvu5TT78O60Mx8v5Hbjd80JysgHyLuzZ5h7cLPvI931YzzpLWkdq5ZxdNMgQDelw0688ah1RjSE-SzyILFV3hWOLhnxtm0_ELDZSxCxDEkaQab3D2rvLyQ97FVLjXuPanY373HUS6s4-gNn52XR0EfctE2LNeL6KubOJQz37-GctfGWeXEpdFNY6S5NaGqUtZ9yowmWJS2umDDNOKUcp4mQyegD7TdvYQyASTSnKDS5RJEwYLV1Rp4lJFeJHde0iOEblVt83RTGqYExQXvmxoPwInm7V_i-hFwGQnYRafvGpZiKvxpej6nRyWr6fTt5VaQQHAbGdYObr6rACJ462EFb99uuqVCIvRCaa0gie7KZx4_hoiGpsu0YZGrpxIaGJ4OEG-t8W9-FVJh795x0fw60stMegcSqPYH-1XNtjJCkrPYQbYi6G4VMdwuBkVJaXeH1zNv4w-QU6ZOb-
link.rule.ids 315,786,790,12083,21416,27580,27581,27887,27955,27956,31752,31753,33777,33778,43343,43838,74100,74657
linkProvider BMJ Publishing Group Ltd
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LbxMxELaglYAL4lVYaMEgxM10d-31erkg1FIFmuRQJSi3lb22aVrYLdkE8fOZcZwAB3qz7NEc5vNjXp4h5LVpKl3mqWWl4pxhpInprDEsz7VIjbRgk-Bv5NFYDqbi86yYRYdbH9MqN3diuKht16CP_BCMbXicC7Cp3l_9YNg1CqOrsYXGTbIrOBe4z8tZufWx5LxUlSxiQaGMy0Pz_eKtBxMA_7PB-J_HaBfl-muTl_h_jTO8PCf3yN2oMtIPa4zvkxuufUBujWJQ_CFZTXtHO08b7b2bt6A8WtrDfbBEQHuqW0sxgTyQLHR_DnPzln7r2q_UztdU1C5Cfkag6dCXjZ50-tOdh6y5d8C7dyymtdNQkvYRmZ58nBwNWOymwIyQxZJJ71IPEGBotCmxaE9RVUYp57zjaVNZbZwU0mrl89RnjdBWWK-1R8Eqm_M9stN2rXtCaAVWFpcWWKhUlNZUXjVZajMN0HLT-IQcgHDrq3W9jDrYGVzWOBeEn5BXG7FfR_QmALKl0ItLzEIri3r85ag-PjseDSdnp3WWkL2A2JYwx5I7QsHC_gbCOp7Mvv6zjxLycrsMZwoDJbp13QpoeGjUBbpOQh6vof-LOUZeRfn0euYvyO3BZDSsh5_Gp8_InTw00eAsq_bJznKxcgegyizN87BffwMvRfGK
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELdgkyZeEF9jgQ0MQryZJnFiJ7wgtFINtlZoWlHfLDu2WflIRtMi_nzuXLfAA3uLnNM9-Gf77nw_3xHywjS1lnlqmaw4Z5hpYjprDMtzXaRGWIhJ8DXyeCJOpsWHWTmL_Kc-0io3Z2I4qG3X4B35AIJtMM4lxFQDH2kRH4ejN1c_GHaQwkxrbKdxk-yClUyxjYOcye19S85lVYsyFhfKuBiY719eeQgH8G0bfP9jmHZxjn9tOIr_9z6DFRrdIbej-0jfrvG-S2649h7ZG8cE-X2ymvaOdp422ns3b8GRtLSHs2GJ4PZUt5YimTyILHR_CWPzln7r2s_UztdS1C4CVyPIdHivjbfq9Ke7DAy616C7dyxS3GkoT_uATEfvLo5PWOyswEwhyiUT3qUe4MA0aSOxgE9Z16aqnPOOp01ttXGiEFZXPk991hTaFtZr7TkHOG3O98lO27XugNAaIi4uLKio0kJaU_uqyVKbaYCZm8Yn5AgmV12ta2eoEHNwoXAsTH5Cnm-m_TqhlwGQrYRefEVGmizV5NOxGp4Px2cX56cqS8h-QGwrmGP5naKCH4cbCFXcpb36s6YS8mz7G_YXJk1067oVyPDQtAv8noQ8XEP_l3LMwhby0fXKn5I9WKrq7P3k9DG5lYd-Gpxl9SHZWS5W7gi8mqV5Epbrb11l9bY
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Use+of+caffeinated+substances+and+risk+of+crashes+in+long+distance+drivers+of+commercial+vehicles%3A+case-control+study&rft.jtitle=BMJ+%28Online%29&rft.au=Sharwood%2C+Lisa+N&rft.au=Elkington%2C+Jane&rft.au=Meuleners%2C+Lynn&rft.au=Ivers%2C+Rebecca&rft.date=2013-03-19&rft.eissn=1756-1833&rft.volume=346&rft.spage=f1140&rft_id=info:doi/10.1136%2Fbmj.f1140&rft_id=info%3Apmid%2F23511947&rft.externalDocID=23511947
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0959-8138&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0959-8138&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0959-8138&client=summon